← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 1, 2018Last known activity
Sep 1, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 5 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Recent trials (7)
- NCT05994339Reponsible party - principal investigatorPhase 2/Phase 3Sep 1, 2023
- NCT05994339Lead sponsorPhase 2/Phase 3Sep 1, 2023
- NCT05527470CollaboratorPhase 3Nov 11, 2022
- NCT05097209Overall official - principal investigatorPhase 3Nov 1, 2021
- NCT05097209CollaboratorPhase 3Nov 1, 2021
- NCT04350190CollaboratorPhase 2May 1, 2020
- NCT03612219CollaboratorPhase 2Jul 1, 2018
Details
- Last known activity
- Sep 1, 2023